Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
Date:9/30/2013

re, for the same period in 2012.The decrease in net loss for the quarter ended June 30, 2013 compared to the net loss for the quarter ended June 30, 2012 was mainly the result of a decrease in costs related to our bremelanotide for FSD program. 

Palatin's net loss for the year ended June 30, 2013 was $20.9 million, or $(0.21) per basic and diluted share, compared to a net loss of $17.3 million, or $(0.49) per basic and diluted share, for the year ended June 30, 2012. 

The increase in net loss for the year ended June 30, 2013 compared to the net loss for the year ended June 30, 2012 was mainly attributable to the recognition of a $7.1 million non-cash charge to expense for the increase in the fair value of warrants related to the July 3, 2012 private placement offering partially offset by the decrease in costs related to our bremelanotide for FSD program.

Revenue
There were no revenues recorded in the quarter ended June 30, 2013, compared to $11,000 for the same period in 2012.  For the year ended June 30, 2013, revenues were $10,000, compared to $74,000 for year ended June 30, 2012.  Revenue consisted entirely of reimbursement of development costs and per-employee compensation earned at the contractual rate pursuant to Palatin's license agreement with AstraZeneca. 

Operating Expenses
For the quarter ended June 30, 2013, total operating expenses were $4.7 million compared to $5.7 million for the comparable quarter of 2012.  For the year ended June 30, 2013, total operating expenses were $15.6 million compared to $18.9 million for the year ended June 30, 2012. The decreases in operating expenses for the respective periods was primarily the result of  a decrease in costs related to our bremelanotide for FSD program, and secondarily as a result of closing our research laboratory operations in connection with the lease expiration of our laboratory facilities in July 2012.

Cash Position
Pal
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
2. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
3. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
4. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
5. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
6. Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
7. CanCHEW Bio-Technologies, a Medical Marijuana Inc. Product, Dr. George Anastassov Appeared on Small Cap Voice Internet Radio Program To Discuss The CanCHEW Advantage
8. Drug Discovery Technologies, BCC Research
9. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
10. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
11. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced ... older adults suffering from the severe cold weather that has ... committed to helping those in need; so to support these ... contributions up to $250,000, which could mean up to $500,000 ...
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB ... composition of matter, biological targets, mechanism of action, methods ... This patent application describes a novel class ... which interfere with the basic homeostatic cellular processes in ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Inc. (NYSE AMEX: ULU ), announced today that ... AG, a company based in Switzerland, to license Altrazeal® for the ... will license the European Union rights to a subsidiary of Melmed ... In exchange for the license ULURU will receive a licensing payment ...
... 12, 2011 CardioFocus, Inc., developer of the HeartLight™ ... fibrillation (AF), announces that its HeartLight EAS was used ... rhythm in a persistent AF patient during a live ... in Venice, Italy. Additionally, research presented ...
Cached Medicine Technology:ULURU Inc. Announces Altrazeal® Agreement for the European Market 2ULURU Inc. Announces Altrazeal® Agreement for the European Market 3Persistent AF Patient Treated with HeartLight™ Endoscopic Ablation System in Live Case at Venice Arrhythmias 2011 2Persistent AF Patient Treated with HeartLight™ Endoscopic Ablation System in Live Case at Venice Arrhythmias 2011 3
(Date:7/9/2014)... has been a sharp increase in the number of ... the online, interactive service that allows patients to view ... schedule appointments, and renew prescriptions. , Over a six-year ... each year increased five-fold, while the number of ... to a study by Dr. David Gerber , ...
(Date:7/9/2014)... Cup highlights, Brian Williams refreshing old school rap classics, ... railings. A University of Colorado Cancer Center study published ... YouTube also allows researchers, journals, and health advocates to ... cancer and prevention. , "No matter what field you,re ... communicate around the world," says Chante Karimkhani, MD candidate ...
(Date:7/9/2014)... of the most important organs in the human body. ... food properly this is its synthesis function ... this is its detoxification function. Lack of exercise ... damage the liver. The resulting diseased cells can lead ... liver failure. According to the German Liver Foundation, over ...
(Date:7/9/2014)... studies linking older age with kidney and heart disease ... donation among older adults. However, in the first study ... Perelman School of Medicine at the University of Pennsylvania ... enjoy similar life expectancy and cardiovascular health as very ... In light of the ever increasing organ transplant waitlists, ...
(Date:7/9/2014)... dramatically in Western societies. One frequently cited reason is ... fewer infections than previous generations, thereby delaying maturation of ... Sahlgrenska Academy, University of Gothenburg, monitored children until the ... system in relation to allergic disease. All of the ... Region, half of them on farms that produced milk.,Lower ...
Breaking Medicine News(10 mins):Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Study of dermatology on YouTube shows new ways science reaches public 2Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Penn study finds living kidney donation does not increase risk of death or heart disease for older 2
... A news study finds that the worse a woman,s skin ... lower her bone density is. The results will be presented ... "In postmenopausal women the appearance of the skin may ... previously described," said Lubna Pal, MD, a reproductive endocrinologist and ...
... , SATURDAY, June 4 (HealthDay News) -- The ... than previously thought, a new study suggests. Prior research ... such as gastric bypass, have an increased risk for bone ... of fracture compared to the general population. But further ...
... diagnosis of breast cancer are more likely to survive the ... be presented Saturday at The Endocrine Society,s 93rd Annual Meeting ... cancer survivors, found that obesity is strongly linked to death ... with a history of estrogen receptor-positive breast cancer, but not ...
... announcement at the American Society of Clinical Oncology annual ... of breast cancer in high-risk, postmenopausal women is the ... trial in which University at Buffalo researchers and hundreds ... The findings will be published online June 4 ...
... -- College athletes who suffer a concussion may experience ... is a head injury that can cause headache, dizziness, ... as well as difficulty following instructions. "This study ... student-athletes," study author Robert Gardner, a student at ...
... treatment for cancer, they want to bounce back to their ... Northwestern Medicine study -- one of the largest survivor studies ... severe problems with pain, fatigue, sleep, memory and concentration three ... surprised to see how prevalent these symptoms still are," said ...
Cached Medicine News:Health News:Severity of facial wrinkles may predict bone density in early menopause 2Health News:Weight-Loss Surgery Linked to Rise in Fracture Risk 2Health News:Obesity raises breast cancer survivors' risk of dying of the cancer 2Health News:UB played major role in study on drug that reduces breast cancer in high-risk women 2Health News:UB played major role in study on drug that reduces breast cancer in high-risk women 3Health News:Concussions Tied to Verbal Memory Loss in Young Athletes 2Health News:Cancer survivors can't shake pain, fatigue, insomnia, foggy brain 2Health News:Cancer survivors can't shake pain, fatigue, insomnia, foggy brain 3
... laser system with intensities up to 30W, ... design for easy handling and transportation, plus ... leader in a new generation of CO2 ... laser devices, like safety and reliability, are ...
... to choose. The Apogee Elite contains ... Alexandrite laser and a high powered ... one convenient unit. The Elite ... hair removal, pigmented lesions, facial and ...
Reusable Components Compatible with VERSASTEP™ Reposable Access System....
VERSASTEP™ Reposable Short Single-Use For use with VERSASTEP™ Short Reusable Cannula, Dilator....
Medicine Products: